| Title: |
271P Eribulin (E) plus endocrine therapy (ET) in patients (pts) with HR[+]/HER2[-] metastatic breast cancer (mBC) after progression on previous ET: The REVERT study |
| Authors: |
Lopez Gonzalez, A.; Del Barco Berron, S.; Garau Llinas, I.; Galan Gramaje, M.; Castelo, B.; Cortes Salgado, A.; Sanchez-Rovira, P.; Martinez Bueno, A.; García, A.; Gener, P.; Mina, L.; Alcalá, D.; Sampayo-Cordero, M.; Cortés, J.; Perez Garcia, J.M.; Llombart Cussac, A.; Lopez Miranda, E. |
| Source: |
Annals of Oncology ; volume 33, page S661-S662 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2022 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.annonc.2022.07.1855 |
| Availability: |
http://dx.doi.org/10.1016/j.annonc.2022.07.1855; https://api.elsevier.com/content/article/PII:S0923753422037061?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753422037061?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.5893E1CB |
| Database: |
BASE |